Phase I Clinical Trial of Oxaliplatin in Children and Adolescents With Refractory Solid Tumors Oligonucleotide array comparative genomic hybridization (aCGH) was performed on 42 microdissected ...

Oligonucleotide microarray (DNA chip)–based hybridization analysis is a promising new technology which potentially allows rapid and cost–effective screens for all possible mutations and sequence ...

Array technologies create an opportunity to identify diagnostic and prognostic markers, as well as drug targets, from clinical samples. We have developed a mid-density spotted oligonucleotide array ...

Chief technology officer Don Montgomery explains that CombiMatrix's system synthesizes oligonucleotide probes directly on the chip through electrochemical methods. As a result, no mechanical parts are ...

Separately, OGT obtains rights to NimbleGen’s DNA microarrays. NimbleGen Systems licensed Oxford Gene Technology’s (OGT) Southern array patents covering the manufacture and commercialization of ...

Microarrays have been a mainstay of the scientific research community for nearly a decade but given the more stringent demands for accuracy and reliability, have not been as closely embraced in the ...

Oligonucleotide array comparative genomic hybridization (aCGH) was performed on 42 microdissected high-grade serous ovarian tumor samples. aCGH segments were obtained and a prediction Cox model was ...